Workflow
Will Toll Brothers' $13.75 EPS Target Hold Amid Softer Sales Volumes?
ZACKS· 2025-09-15 21:31
Key Takeaways Toll Brothers targets fiscal 2025 EPS of $13.75, down from $13.82 in fiscal 2024.Q3 deliveries rose 5% and revenues gained 6%, but net signed contracts fell 4% year over year.Backlog units dropped 19%, yet average backlog price rose to $1.161M, showing buyer resilience.Toll Brothers, Inc. (TOL) operates in a housing market shaped by affordability constraints, shifting buyer preferences and volatile mortgage rates. The luxury builder continues to emphasize price discipline and operational effic ...
Stonegate Capital Partners Initiates Coverage on Seabridge Gold Inc. (SA)
Newsfile· 2025-09-15 21:31
Stonegate Capital Partners Initiates Coverage on Seabridge Gold Inc. (SA)September 15, 2025 9:31 AM EDT | Source: Reportable, Inc. Dallas, Texas--(Newsfile Corp. - September 15, 2025) - Seabridge Gold Inc. (NYSE: SA): Stonegate Capital Partners initiates their coverage on Seabridge Gold Inc. (NYSE: SA). As of 2Q25, Seabridge Gold maintained a robust financial position, with cash and cash equivalents of $121.4 million, supported by a US$100.2 million equity financing in February 2025 and a $30. ...
FOMC Leads Market Discussions, Near Certain 25bps Rate Cut
Youtube· 2025-09-15 21:30
Kevin Hanks, co-host of Fast Market, live at the CBOE is here and of course the latest with the trade talks between the US and China. It's the fourth meeting in fourth month and um so big news there. Some of your thoughts.Good morning, Kevin. >> Good morning, Nicole. Yeah, futures higher to start the week.You've got news out of really all over the place, Nicole. You've got news to start the week in a week that's already going to be enormous as we get to midweek as the Fed is expected to move on interest rat ...
Occidental Petroleum: Streamlined/Efficient Operations Trigger Richer Cash Flow Story
Seeking Alpha· 2025-09-15 21:30
I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ...
SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea
Accessnewswire· 2025-09-15 21:30
CHINO HILLS, CALIFORNIA / ACCESS Newswire / September 15, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing and Cell Engineering is pleased to announce that it has received a Notice of Allowance/Approval from the South Korea Patent Office for its innovative technology entitled - "CAS9 Retroviral Integrase and CAS9 Recombinase Systems for Targeted Incorporation of a DNA Sequence into a Genome of a Cell or ...
CIM Group Advances Hospitality Lending Focus Closing $73.5 Million for Two Hilton Brand Hotels in Louisiana and Pennsylvania
Businesswire· 2025-09-15 21:30
LOS ANGELES--(BUSINESS WIRE)--CIM Group closes loans totaling $73.5 million backed by two Hilton branded hotels. ...
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor
Prnewswire· 2025-09-15 21:30
合作进展 - 合作伙伴BioAge Labs启动BGE-102的1期临床研究 该药物是一种新型口服小分子NLRP3抑制剂 由HitGen的DNA编码库(DEL)技术平台筛选出的先导化合物开发而成 [1][2][6] - BGE-102临床启动触发合作协议中未披露金额的里程碑付款 [1][6] - 双方自2021年4月宣布成功识别先导分子 2024年2月在《生物有机与药物化学通讯》联合发表研究成果 并提交共同专利覆盖DEL筛选发现的结构新颖化合物 [3] 技术平台优势 - HitGen的DEL技术平台包含超过1.2万亿个小分子 筛选效率支持全球多家机构的药物发现项目 [4] - 平台结合人工智能和自动化DMTA循环 加速临床前候选化合物优化 [5] - 技术应用范围涵盖小分子药物、核酸药物、蛋白降解疗法等领域 [5] 药物特性与适应症 - BGE-102具有高效力和脑渗透性 针对NLRP3靶点开发 该靶点是年龄相关炎症的关键驱动因素 涉及神经退行性疾病、心血管疾病及肥胖等代谢紊乱疾病 [2][7] - 临床前数据显示BGE-102作为单药或与GLP-1受体激动剂联用均能显著减轻体重 [7] - BioAge同步开发长效注射剂和口服小分子APJ激动剂用于肥胖治疗 [7] 商业合作模式 - HitGen通过多样化商业模式与全球数百家生物制药研究机构建立合作 多个项目处于早期发现至临床试验阶段 [5] - 合作案例证明DEL尖端筛选技术与人类衰老生物学洞察结合的价值 [4]
Element79 Gold Corp. Announces Changes to Board of Directors with Eye to Drive Corporate Growth
Thenewswire· 2025-09-15 21:30
Vancouver, British Columbia – TheNewswire - September 15, 2025 - Element79 Gold Corp. (CSE: ELEM) (FSE: 7YS0) (OTC: ELMGF) (the "Company" or “Element79”) announces that its Board of Directors has accepted the resignation of Ms. Zara Kanji as Director of the Company, effective immediately. The Board and management thank Ms. Kanji for her valuable contributions to the Company and wish her the very best in her current and future endeavors.At the same time, the Board is pleased to announce the appointment of M ...
FactSet: Dividend Aristocrat That Appears To Be On Sale
Seeking Alpha· 2025-09-15 21:30
Founder of Dividend Mantra. Founder of Mr. Free At 33. Co-Founder of Dividends & Income. I started blogging about my journey to financial independence back in 2011. By living well below my means and intelligently investing my hard-earned capital, I went from below broke at age 27 to financially free at 33 years old. I regularly create content on dividend growth investing, living off of dividends, undervalued high-quality dividend growth stocks, high-yield situations, and other long-term investment opportuni ...
Trading SPY, Top Tech Stocks Using Technical Analysis
Benzinga· 2025-09-15 21:29
Good Morning Traders! Today’s economic calendar launches the week on Monday, September 15, 2025, with a very light schedule that may not generate significant market momentum at the outset. At 8:30 AM ET, the Empire Manufacturing data for September was released, offering a regional snapshot of industrial activity, though its impact is typically modest. At 11:30 AM ET, the Treasury's 3-Month and 6-Month Bill Auction will assess short-term debt demand, potentially causing minor yield adjustments but lacking ma ...